[Skip to Content]
[Skip to Content Landing]
Views 1,254
Citations 0
JAMA Oncology Patient Page
February 13, 2020

Brachytherapy

Author Affiliations
  • 1Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas
  • 2Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas
JAMA Oncol. Published online February 13, 2020. doi:10.1001/jamaoncol.2019.5882
What Is Brachytherapy?

Radiotherapy is a cancer treatment that involves the targeted use of high-energy light or particles to kill cancer. Radiation is usually delivered externally, or from outside of the body, and focused at the tumor. This may cause damage to organs that are in the path of the radiation beam. Internal radiation, or brachytherapy, is a different approach that involves placing radioactive sources into or near the tumor itself. Very high doses of radiation are delivered from the inside out, killing cancer cells and decreasing the risk of damage to nearby organs. The placement of radioactive sources (or seeds) internally is often called an implant.

How Is Brachytherapy Delivered?

There are many brachytherapy techniques. The recommended procedure is based on the size and location of the tumor as well as the expertise of the treating radiation oncologist. These procedures can be done in clinic or on an outpatient basis with the patient under general anesthesia.

Source placement can be permanent or temporary. With permanent placement, radioactive seeds are placed during a single procedure and left inside of the body. Permanent seeds lose their energy over time and essentially become inactive after a few weeks. With temporary placement, hollow catheters are placed into the tumor, allowing radioactive sources to temporarily enter the body, and then are removed after the procedure. Temporary implants may be spread out over multiple treatments to decrease the risk of adverse effects.

Is Brachytherapy Safe?

Yes. Internal radiation has been safely used since 1901 to kill cancer cells. Multiple members of the radiation treatment team help ensure the safety of internally delivered radiation, including radiation oncologists, medical physicists, nurses, and support staff. This treatment is highly regulated locally and nationally to ensure that it will not be harmful to patients or other individuals. Specific measures include the following:

  • Quality checks on the radioactive seeds

  • Preprocedure planning of source placement

  • Visualization of the tumor during the procedure using ultrasonography, radiography, computed tomography, or magnetic resonance imaging scans

  • Postprocedure imaging to confirm placement

What Happens After the Procedure?

After receiving internal radiation treatment, patients can maintain their normal life activities with minimal adverse effects and do not carry a risk of exposing others to radiation. Adverse effects are related to the location of treatment. For example, patients with cervical cancer may have burning during urination or diarrhea; patients with skin cancer may experience a sunburn-type reaction. Adverse effects generally subside within a month of treatment. If a permanent implant is placed, patients may be asked to limit close contact with children and pregnant women for a given time (weeks to 2 months) as a precautionary measure.

Which Cancers Are Treated With Brachytherapy?

Brachytherapy can be used to treat prostate, cervical, uterine, skin, eye, and breast cancers. In special cases, it may also be used in other sites, such as rectal, head and neck, brain, bile duct, and lung tumors.

Box Section Ref ID
Section Editor: Howard (Jack) West, MD.
The JAMA Oncology Patient Page is a public service of JAMA Oncology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Oncology suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, email reprints@jamanetwork.com.
Back to top
Article Information

Published Online: February 13, 2020. doi:10.1001/jamaoncol.2019.5882

Conflict of Interest Disclosures: None reported.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×